Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artelo Biosciences, Inc.

0.9538
-0.0162-1.67%
Post-market: 0.8835-0.0703-7.37%19:49 EDT
Volume:125.46K
Turnover:115.73K
Market Cap:3.08M
PE:-0.31
High:0.9600
Open:0.9103
Low:0.8808
Close:0.9700
Loading ...

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 Apr

New Strong Sell Stocks for March 6th

Zacks
·
06 Mar

Artelo Biosciences Reports 2024 Financial Results and Clinical Progress

TIPRANKS
·
06 Mar

Artelo Biosciences Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
03 Mar

Artelo Biosciences FY 2024 GAAP EPS $(3.05) Misses $(2.44) Estimate

Benzinga
·
03 Mar

Artelo Biosciences FY Net Income USD -9.8 Million

THOMSON REUTERS
·
03 Mar

Press Release: Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results

Dow Jones
·
03 Mar

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
27 Feb

Artelo Biosciences announces new data on ART12.11

TIPRANKS
·
14 Feb

Artelo Biosciences Announces New Data on Art12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®

THOMSON REUTERS
·
14 Feb

Alpha Real Trust Acquires Five Crematoria In England For £34.2m

T-Reuters
·
21 Jan

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
14 Jan

Artelo Biosciences completes first cohort in Phase 1 study of ART26.12

TIPRANKS
·
13 Jan

Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of Art26.12

THOMSON REUTERS
·
13 Jan

Artelo Biosciences Inc - Initial Safety and Pharmacokinetic Data Expected First Half 2025

THOMSON REUTERS
·
13 Jan

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
10 Dec 2024

Artelo Biosciences Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Dec 2024

Analysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
09 Dec 2024

Artelo presents Phase 1 data with ART27.13 in cancer-related anorexia

TIPRANKS
·
09 Dec 2024